SCHEMBL13323409

SCHEMBL13323409

CCN(CC)[C@H](Cc1ccc(Cl)cc1)C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.42
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 1/20 0.42
ACACB O00763 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
PPARG P37231 4/20 0.41
PPARA Q07869 3/20 0.41
SLC6A4 P31645 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
BRD4 O60885 1/20 0.40
PSMB5 P28074 1/20 0.39
EPHX2 P34913 1/20 0.39
CTSC P53634 1/20 0.39
CNR2 P34972 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
C5AR1 P21730 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13323476 1.00 HTT (0.42) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL5534990 0.85 SLC6A2 (0.44) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL16450888 0.83 ALPI (0.47) ALDH1A1RAB9AMEN1LMNAKMT2A
SCHEMBL684451 0.83 ALDH1A1 (0.45) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL13323473 0.83 ALDH1A1 (0.45) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL3773871 0.80 SLC6A2 (0.52) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL16151904 0.79 ADAMTS5 (0.45) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL15454448 0.78 SLC6A2 (0.50) HTTALDH1A1RAB9AACACBSLC6A2
SCHEMBL5774507 0.75 PPARG (0.53) ACACBSLC6A2SLC6A3PPARGPPARA
SCHEMBL3778897 0.75 ACACB (0.43) HTTALDH1A1ACACBSLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718802-B2 Agonist or antgonist and binders and inversion of agonist; use in the treatment of metabolic, immune, infection-related and melanocortin receptor mediated disorders PALATIN TECHNOLOGIES, INC. (US) 2010-05-18 US disclosed
US-7718802-B2 Agonist or antgonist and binders and inversion of agonist; use in the treatment of metabolic, immune, infection-related and melanocortin receptor mediated disorders PALATIN TECHNOLOGIES, INC. (US) 2010-05-18 US disclosed
US-7709484-B1 Substituted melanocortin receptor-specific piperazine compounds PALATIN TECHNOLOGIES, INC. (US) 2010-05-04 US disclosed
US-7709484-B1 Substituted melanocortin receptor-specific piperazine compounds PALATIN TECHNOLOGIES, INC. (US) 2010-05-04 US disclosed